Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma-Reference-Cited by-同舟云学术

Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma

Published:2018-12-02 Issue:12 Volume:53 Page:1575-1583
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Endo Kei¹,Kuroda Hidekatsu¹,Oikawa Takayoshi¹,Okada Yohei¹,Fujiwara Yudai¹,Abe Tamami¹,Sato Hiroki¹,Sawara Kei¹,Takikawa Yasuhiro¹

Affiliation:

1. Division of Hepatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Morioka, Japan

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2018.1548645

Reference29 articles.

1. Global cancer statistics, 2012

2. Management of hepatocellular carcinoma: An update

3. EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

4. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

5. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic analysis of 632 cases treated by transcatheter arterial chemoembolization combined with ablation in hepatocellular carcinoma: A retrospective study;European Journal of Radiology;2024-09

2. Recurrence of Hepatocellular Carcinoma in Patients with Low Albumin-Bilirubin Grade in TACE Combined with Ablation: A Random Forest Cox Predictive Model;Journal of Hepatocellular Carcinoma;2024-07

3. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Kurzversion;Zeitschrift für Gastroenterologie;2024-02

4. S3-Leitlinie „Diagnostik und Therapie biliärer Karzinome“ – Langversion 4.0;Zeitschrift für Gastroenterologie;2024-02

5. S3-Leitlinie „Diagnostik und Therapie des Hepatozellulären Karzinoms“ – Kurzversion;Zeitschrift für Gastroenterologie;2024-01